We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
National marketing campaign launches today, targeting those eligible but still unvaccinated.
Data on the real-world efficacy of the COVID-19 vaccines.
VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Information for healthcare professionals and the public about the Pfizer/BioNTech's bivalent vaccines
Description of UKHSA adult surveillance programmes for COVID-19.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Guidance on the ventilation of indoor spaces to reduce the spread of respiratory infections, including coronavirus (COVID-19).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).